Nitazoxanide: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett mNo edit summary |
mNo edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
In [[medicine]], '''nitazoxanide''' is an [[antiprotozoal agent]] "5-nitrothiazolyl derivative used for a broad range of intestinal parasitic infections including [[cryptosporidium]] and [[giardia]]; it is a redox-active nitrothiazolyl-salicylamide prodrug; structure given in first source."<ref>{{MeSH}}</ref> | In [[medicine]], '''nitazoxanide''' is an [[antiprotozoal agent]] "5-nitrothiazolyl derivative used for a broad range of intestinal parasitic infections including [[cryptosporidium]] and [[giardia]]; it is a redox-active nitrothiazolyl-salicylamide prodrug; structure given in first source."<ref>{{MeSH}}</ref> | ||
| Line 4: | Line 5: | ||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 06:01, 26 September 2024
In medicine, nitazoxanide is an antiprotozoal agent "5-nitrothiazolyl derivative used for a broad range of intestinal parasitic infections including cryptosporidium and giardia; it is a redox-active nitrothiazolyl-salicylamide prodrug; structure given in first source."[1]
It may also be effective for the treatment of pseudomembranous enterocolitis.[2]
References
- ↑ Anonymous (2024), Nitazoxanide (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Musher DM, Logan N, Bressler AM, Johnson DP, Rossignol JF (January 2009). "Nitazoxanide versus Vancomycin in Clostridium difficile Infection: A Randomized, Double-Blind Study". Clin. Infect. Dis.. DOI:10.1086/596552. PMID 19133801. Research Blogging.